nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An Evidence-Based Guide to Cholesterol-Lowering Guidelines
|
Waters, David D. |
|
2017 |
33 |
3 |
p. 343-349 7 p. |
artikel |
2 |
Barriers to the Implementation of Lipoprotein Apheresis in Canada
|
Filler, Guido |
|
2017 |
33 |
3 |
p. 409-411 3 p. |
artikel |
3 |
Cardiovascular Risk Factor Management Performance in Canada and the United States: A Systematic Review
|
Alabousi, Mostafa |
|
2017 |
33 |
3 |
p. 393-404 12 p. |
artikel |
4 |
Contemporary Trends in the Management and Outcomes of Patients With Familial Hypercholesterolemia in Canada: A Prospective Observational Study
|
Brunham, Liam R. |
|
2017 |
33 |
3 |
p. 385-392 8 p. |
artikel |
5 |
Diabetes for Cardiologists: Practical Issues in Diagnosis and Management
|
Mancini, G.B. John |
|
2017 |
33 |
3 |
p. 366-377 12 p. |
artikel |
6 |
Editorial Board
|
|
|
2017 |
33 |
3 |
p. A2-A3 nvt p. |
artikel |
7 |
Effective Management of Cardiovascular Risk Factors—Are We Doing Enough?
|
Teo, Koon K. |
|
2017 |
33 |
3 |
p. 300-302 3 p. |
artikel |
8 |
Familial Hypercholesterolemia: Awareness, Appraisal, and Action
|
Genest, Jacques |
|
2017 |
33 |
3 |
p. 298-299 2 p. |
artikel |
9 |
Genetics for the Identification of Lipid Targets Beyond PCSK9
|
Wang, Linda R. |
|
2017 |
33 |
3 |
p. 334-342 9 p. |
artikel |
10 |
High-Density Lipoproteins: Biology, Epidemiology, and Clinical Management
|
Choi, Hong Y. |
|
2017 |
33 |
3 |
p. 325-333 9 p. |
artikel |
11 |
Information for Readers
|
|
|
2017 |
33 |
3 |
p. A7- 1 p. |
artikel |
12 |
Macrophage Apoptosis and Necrotic Core Development in Atherosclerosis: A Rapidly Advancing Field with Clinical Relevance to Imaging and Therapy
|
Gonzalez, Leticia |
|
2017 |
33 |
3 |
p. 303-312 10 p. |
artikel |
13 |
MicroRNAs in the Pathobiology and Therapy of Atherosclerosis
|
Laffont, Benoit |
|
2017 |
33 |
3 |
p. 313-324 12 p. |
artikel |
14 |
New Drugs for Atherosclerosis
|
Bruikman, Caroline S. |
|
2017 |
33 |
3 |
p. 350-357 8 p. |
artikel |
15 |
Optimal Low-Density Lipoprotein Cholesterol for Cardiovascular Prevention: How Low Should We Go?
|
Anderson, Todd J. |
|
2017 |
33 |
3 |
p. 405-408 4 p. |
artikel |
16 |
Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact
|
Tu, Jack V. |
|
2017 |
33 |
3 |
p. 378-384 7 p. |
artikel |
17 |
Table of Contents
|
|
|
2017 |
33 |
3 |
p. A5-A6 nvt p. |
artikel |
18 |
The Emerging Epidemic of Cardiovascular Risk Factors and Atherosclerotic Disease in Developing Countries
|
Teo, Koon K. |
|
2017 |
33 |
3 |
p. 358-365 8 p. |
artikel |
19 |
The Rise and Fall of Tuberculosis and Atherosclerosis: First There Is a Mountain…
|
Waters, David D. |
|
2017 |
33 |
3 |
p. 295-297 3 p. |
artikel |
20 |
Three-Dimensional and Conventional Carotid Ultrasound for Assessment of Carotid Plaque in a Stroke Patient: A Simple Way to Validate Findings
|
Kalashyan, Hayrapet |
|
2017 |
33 |
3 |
p. 412.e1-412.e3 407881 p. |
artikel |